Search Results
Search for other papers by Kristine Z Swan in
Google Scholar
PubMed
Search for other papers by Johnson Thomas in
Google Scholar
PubMed
Search for other papers by Viveque E Nielsen in
Google Scholar
PubMed
Search for other papers by Marie Louise Jespersen in
Google Scholar
PubMed
Search for other papers by Steen J Bonnema in
Google Scholar
PubMed
annotations, markings, writings, or crosshairs within the nodule were excluded. Multinodular goiters without a separable nodule on the ultrasound image, medullary thyroid cancer, metastasis from other cancers, thyroid lymphomas, and purely cystic nodules were
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Search for other papers by Gilles Russ in
Google Scholar
PubMed
Search for other papers by Fernando Schmitt in
Google Scholar
PubMed
Search for other papers by Paula Soares in
Google Scholar
PubMed
Search for other papers by Tamas Solymosi in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
case of personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 ( 27 ). Cut-off points to separate non-medullary reasons for increased calcitonin from medullary thyroid carcinoma have been established (>30 pg/mL in
Search for other papers by Maria Mavromati in
Google Scholar
PubMed
Search for other papers by Essia Saiji in
Google Scholar
PubMed
Search for other papers by Marco Stefano Demarchi in
Google Scholar
PubMed
Search for other papers by Vincent Lenoir in
Google Scholar
PubMed
Search for other papers by Amanda Seipel in
Google Scholar
PubMed
Search for other papers by Paulina Kuczma in
Google Scholar
PubMed
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
Search for other papers by Minerva Becker in
Google Scholar
PubMed
Search for other papers by Eugenio Fernandez in
Google Scholar
PubMed
Search for other papers by Claudio De Vito in
Google Scholar
PubMed
Search for other papers by Frédéric Triponez in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
; poorly differentiated thyroid cancer: 5 cases; medullary thyroid cancer: 1 case and intrathyroidal metastasis from renal carcinoma not diagnosed at cytology :1 case). Rates of malignancy (malignancy only and malignancy plus low-risk neoplasm) in the
Search for other papers by Rachelle P Mendoza in
Google Scholar
PubMed
Search for other papers by Richard Cody Simon in
Google Scholar
PubMed
Search for other papers by Nicole A Cipriani in
Google Scholar
PubMed
Search for other papers by Tatjana Antic in
Google Scholar
PubMed
Marotta V Bifulco M & Vitale M . Significance of RAS mutations in thyroid benign nodules and non-medullary thyroid cancer . Cancers 2021 13 . ( https://doi.org/10.3390/cancers13153785 ) 24 Topf MC Wang ZX Tuluc M & Pribitkin EA
Search for other papers by Alessia Cozzolino in
Google Scholar
PubMed
Search for other papers by Tiziana Filardi in
Google Scholar
PubMed
Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
Search for other papers by Ilaria Simonelli in
Google Scholar
PubMed
Search for other papers by Giorgio Grani in
Google Scholar
PubMed
Search for other papers by Camilla Virili in
Google Scholar
PubMed
Search for other papers by Ilaria Stramazzo in
Google Scholar
PubMed
Search for other papers by Maria Giulia Santaguida in
Google Scholar
PubMed
Search for other papers by Pietro Locantore in
Google Scholar
PubMed
Search for other papers by Massimo Maurici in
Google Scholar
PubMed
Search for other papers by Daniele Gianfrilli in
Google Scholar
PubMed
Search for other papers by Andrea M Isidori in
Google Scholar
PubMed
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Search for other papers by Carlotta Pozza in
Google Scholar
PubMed
Search for other papers by on behalf of TALENT Group in
Google Scholar
PubMed
follicular cancer (4.4%), medullary thyroid cancer (2.4%), and Hurtle cell carcinoma (1.1%). Table 1 Details of selected studies. Study name Country Objective of study Study type Reference standard Number of patients (no of cases a